Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
12
self-reported 11–50 band
Founded
2016
10 years
Registry matches
1
ACRA
Office countries
2
2 addresses
Funding rounds
1
Series A · Jun 2018 · US$ 20.0M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 possible registrationMatched by name against ACRA, so this is a candidate list, not a confirmed identity. Confidence and match method are shown against every row.
MEDISIX THERAPEUTICS PTE. LTD.
UEN201627927H
Legal entities
Show as table · MediSix Therapeutics: 1 registry entity
| MEDISIX THERAPEUTICS PTE. LTD. | UEN 201627927H |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
We believe that T-cell therapies will radically change the treatment of cancer and autoimmune diseases. At MediSix, our mission is to develop effective T-cell therapies by leveraging an array of proprietary technologies that improve and expand T cell function.
Specialties
All 4 specialties
- CAR-T therapy
- T cell leukemia
- Therapeutics
- Cell therapy
Locations
2
Countries with an office address2 addresses on record
SingaporeprimaryUnited States
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG US
Addresses
- US500 Boylston Street; Suite 1380; Boston, MA 02116
- SG11 Biopolis Way, Helios, #05-08/09; Singapore, 138667Primary
Grid intelligence Members
Funding
Rounds1
Round typeSeries A · venture round
Amount (USD)20,000,000
Stage rank3
Investors named1
Since last round7 yr 7 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2016 to 2026 |
| Series A · 15 Jun 2018 | US$ 20.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under MediSix Therapeutics?
One Singapore entity on ACRA: MEDISIX THERAPEUTICS PTE. LTD. (UEN 201627927H), medium confidence.
How many people work at MediSix Therapeutics?
12 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does MediSix Therapeutics have offices?
Two addresses on record across 2 countries. Primary: 11 Biopolis Way, Helios, #05-08/09, Singapore 138667.
Has MediSix Therapeutics raised funding?
One round. Latest 15 June 2018: Series A, US$20,000,000, investor Lightstone Ventures.
What does MediSix Therapeutics list as its specialties?
Four tags on the brand's own list, among them CAR-T therapy, T cell leukemia and Therapeutics.
Which companies are listed alongside MediSix Therapeutics?
4 profiles list MediSix Therapeutics as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. PairX Bio and Automera list it back.